Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity

Digestive Diseases and Sciences

Volumn 53, Issue 1, 2008, Pages 242-247

  Nancey, Stéphane ^a   Hamzaoui, Nadim ^a   Moussata, Driffa ^a   Graber, Ivan ^a   Bienvenu, Jacques ^a   Flourie, Bernard ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Crohn's disease; Disease activity; Interleukin 6; Soluble IL 6 receptor

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; SOLUBLE INTERLEUKIN 6 RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; REMISSION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROHN DISEASE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6;

EID: 37249013895     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9849-6     Document Type: Article

References (34)

1. Akira S, Taga T, Kishimoto T (1993) Interleukin 6 in biology and medicine. Adv Immunol 54:1-78
2. Kishimoto T, Akira S, Taga T (1992) Interleukin 6 and its receptor: a paradigm for cytokines. Science 258:593-597
3. Lobo AJ, Evans SW, Jones SC, Banks R, Rathbone BJ, Axon ATR, Whitcher JT (1992) Plasma interleukin 6 in inflammatory bowel disease. Eur J Gastroenterol Hepatol 4:367-372
4. Mahida YR, Kurbac A, Gallagher A, Hawkey CJ (1991) High circulating concentrations of interleukin 6 in active Crohn's disease but not ulcerative colitis. Gut 32:1531-1534
5. Suzuki H, Yasukawa K, Saito T, Narasaki M, Hasegawa A, Taga T (1993) Serum soluble interleukin 6 receptor in MRL/pr mice is elevated with age and mediates the interleukin 6 signal. Eur J Immunol 23:1078-1082
6. Mackiewics A, Wiznerowicz M, Roeb E, Karczewska A, Nowak J, Heinrich PC, et al. (1995) Soluble interleukin-6 receptor is biologically active in vivo. Cytokine 7:142-149
7. Gaillard JP, Bataille R, Brailly H, Zuber C, Yasakawa K, Attal M, Maruo N, Taga T, Kishimoto T, Klein B (1993) Increased and highly stable levels of functional soluble interleukin 6 receptor in sera of patients with monoclonal gammapathy. Eur J Immunol 23:820-824
8. Montero-Julian FA, Liautard J, Flavetta S, Romagne F, Gaillard JP, Brochier J, Klein B, Brailly H (1994) Immunoassay for functional human soluble interleukin 6 receptor in plasma based on ligands/receptor interactions. J Immunol Methods 169:111-121
9. Bernades P, Heckeitsweiler P, Benozio M, Descos L, Geffroy Y, Hemet J, Loygue J, Modigliani R, Potet F, Weill JP (1978) Proposal of a system of criteria for the diagnosis of cryptogenetic inflammatory enterocolitis (Crohn's disease and rectocolitis): a cooperative study by the Cryptogenic Enterocolitis Study Group). Gastroenterol Clin Biol 2:1047-1054
10. Harvey RF, Bradshaw JM (1980) A simple index of Crohn's disease activity. Lancet 1:514
11. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL (1993) Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology 104:1285-1292
12. Gross V, Andus T, Caesar I, Roth M, Schölmerich J (1992) Evidence for continuous stimulation of interleukin 6 production in Crohn's disease. Gastroenterology 102:514-519
13. Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Deviere J, Franchimont D (2005) Profile of soluble cytokine receptors in Crohn's disease. Gut 54:488-495
14. Chirmule N, Oyaizu N, Kalyanaraman VS, Pahwa S (1991) Misinterpretation of results of cytokine bioassays. J Immunol Methods 137:141-144
15. Burger R, Gramatzki M (1993) Responsiveness of interleukin 6 dependent cell line B9 to IL-11. J Immunol Methods 158:147-148
16. Barton BE, Jackson JV, Lee F, Wagner J (1994) Oncostatin M stimulates proliferation in B9 hybridoma cells. Potential role of oncostatin M in plasmacytoma development. Cytokine 6:147-153
17. May LT, Viguet H, Kenney JS, Ida N, Allison AC, Sehgal PB (1989) High levels of complexed interleukin-6 in human blood. J Immunol 142:148-152
18. Matsuda T, Hirano T, Nagasawa S, Kishimoto T (1989) Identification of α2 macroglobulin as a carrier protein for interleukin 6. J Immunol 142:148-152
19. Hosokawa T, Kusugami K, Ina K, Ando T, Shinoda M, Imada A, Ohsuga M, Sakai T, Matsuura T, Ito K, Kaneshiro K (1999) Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease. J Gastroenterol Hepatol 14:987-996
20. Bienvenu J, Coulon L, Doche C, Gutowski MC, Grau GE (1993) Analytical performances of commercial ELISA kits for IL-2, IL-6 and TNFα: a WHO study. Eur Cytokine Netw 4:447-451
21. Zohlnofer D, Graeve L, Rose-John S, Schooltink H, Dittrich E, Heinrich PC (1992) The hepatic interleukin 6 receptor. Down regulation of interleukin 6 binding sub-unit (gp 80) by its ligand. FEBS Lett 306:219-222
22. Ishibashi T, Kimura H, Shikawa Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y (1989) Interleukin 6 is a potent thrombopoietic factor in vivo in mice. Blood 74:1241-1244
23. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakao N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T (1989) IgG1 plasmocytosis in interleukin-6 transgenic mice. Proc Natl Acad Sci U S A 86:7447-7451
24. Hollen CW, Henthorm J, Koziol JA, Burstein SA (1991) Elevated serum interleukin 6 levels in patients with reactive thrombocystosis. Br J Haematol 79:286-290
25. Mitsuyama K, Toyonaga A, Sasaki E, Ishida O, Ikeda H, Tsurata O, Harada K, Tateishi H, Nishiyama T, Tanikawa K (1995) Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 36:45-49
26. Louis E, Belaiche J, Van Kemseke C, Franchimont D, De Groote D, Gueenen V, Mary JY (1997) A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol 9:939-944
27. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF (2000) Blockade of interleukin 6 trans signalling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat Med 6:583-588
28. Taga T, Hibi M, Hirata Y, Yamazaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell 58:573-581
29. Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T (1992) Molecular cloning of a murine IL-6 receptor associated signal transducer, gp 130, and its regulated expression in vivo. J Immunol 148:4066-4071
30. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T (1988) Cloning and expression of the human interleukin 6 (BSF 2/IFN beta 2) receptor. Science 241:825-828
31. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S (1992) Complex of soluble human Il 6 receptor/IL6 up-regulates expression of acute phase proteins. J Immunol 149:2021-2027
32. Vinck A, Coulie PG, Warnier G, Renauld JC, Stevens M, Donckers P, Van Snick J (1990) Mouse plasmocytoma growth in vivo: enhancement by interleukin-6 and inhibition by antibodies directed against IL-6 or its receptor. J Exp Med 172:997-1000
33. Suzuki H, Yasukawa K, Saito T, Anzai M, Goitsuka R, Hasegawa A, Ohsugi Y, Taga T, Kishimoto T (1992) Antihuman interleukin 6 receptor antibody inhibits human myeloma growth in vivo. Eur J Immunol 22:1989-1993
34. Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, Hayden K, Jagannath S, Barlogie B (1994) Brief report: alleviation of systemic manifestations of Casteman's disease by monoclonal anti interleukin 6 antibody. N Engl J Med 330:602-605